Latest Firebrick Pharma (ASX:FRE) News
Page 1
Page 1 of 3
Firebrick takes Nasodine to US pharmacy shelves with 2.2 quarters of cash
23 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Firebrick wins Philippine OTC approval for Nasodine with Q1 2027 launch possible
16 Oct 2026
Firebrick’s Philippines Partner Takes Stake Above 10% in $732k Placement
12 Oct 2026
Healthcare Wrap - Week 40 (28 Sept -> 2 Oct) 2026
3 Oct 2026
Firebrick Targets US Pharmacy Shelves After Nasodine Online Sales Surge
29 Sept 2026
Healthcare Wrap - Week 39 (21 Sept -> 25 Sept) 2026
26 Sept 2026
Firebrick receives $293,000 R&D payment as Nasodine pipeline expands
23 Sept 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Firebrick Pharma Secures New Patents and Reports 43% Sales Growth Amid Stable Cash Burn
27 July 2026
Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026
25 Apr 2026
Firebrick Pharma Advances Southeast Asia Expansion with Indonesia Approval and $1.5M Raise
21 Apr 2026